ethics committee presentation

Radium 223 combined with new hormone therapies for the treatment of castrate-resistant metastatic prostate cancer: scientific evidence and sharing of our experience.

by
Radium 223 combined with new hormone therapies for the treatment of castrate-resistant metastatic prostate cancer: scientific evidence and sharing of our experience.
Presentation of the attention-grabbing case of a affected person affected by castrate-resistant prostate most cancers (CRPC) with bone metastasis, who obtained concomitant treatment with abiraterone acetate (AA) and radium-223. The affected person skilled important scientific enchancment in his high quality of life and ache aid after starting the aforementioned treatment, with out being affected by opposed toxicities.
Currently, the appropriate choice of sufferers to obtain radium-223 treatment remains to be a scientific problem in the case of CRPC with metastasis. In this text, we talk about the future prospects of this treatment, reviewing present evidence about concomitant therapies with radium-223 and its current state, primarily based upon the current suggestions from the Pharmacovigilance Risk Assessment Committee (PRAC), and the knowledge offered in the ERA-223 examine.
Based on our scientific expertise, we offer sensible orientation for the integration of this radiopharmaceutical in the therapeutic plan for this group of sufferers. We conclude, regardless of some of the constructive outcomes and our wonderful expertise, that it will be clever to attend for the outcomes of the scientific trials which are finding out the security and advantages of the combined use of radium-223 with new hormone therapies.
Bearing in thoughts that to this point, the solely revealed large-scale randomised trial that investigated the mixture of AR-axis-targeted remedy with Ra-223 is unfavourable, the harms of the mixture outweighed any advantages in ERA-223. Nonetheless, with a purpose to advocate whether or not or not this treatment must be used, it’s important to outline the affected person profile that would profit from this therapeutic possibility.
Radium 223 combined with new hormone therapies for the treatment of castrate-resistant metastatic prostate cancer: scientific evidence and sharing of our experience.
Radium 223 combined with new hormone therapies for the treatment of castrate-resistant metastatic prostate most cancers: scientific evidence and sharing of our expertise.

Clinical Response to Apatinib Combined With Brain Radiotherapy in EGFR Wild-Type and ALK-Negative Lung Adenocarcinoma With Multiple Brain Metastases.

by
Clinical Response to Apatinib Combined With Brain Radiotherapy in EGFR Wild-Type and ALK-Negative Lung Adenocarcinoma With Multiple Brain Metastases.

Background: Brain radiotherapy is the usual remedy possibility for a number of mind metastases (BMs) from non-small cell lung most cancers (NSCLC), particularly in the absence of a driver mutation. However, the prognosis for such sufferers stays poor. Apatinib is a potent antiangiogenic compound directed on the vascular endothelial progress issue receptor-2 (VEGFR-2); nevertheless, to date, there are not any investigations of apatinib concurrent with mind radiotherapy for NSCLC sufferers with BMs.

We report a case of EGFR wild-type and ALK-negative lung adenocarcinoma affected person with a number of symptomatic BMs, who obtained apatinib along with mind radiation remedy. A positive oncologic consequence was achieved for each mind metastatic lesions and the first pulmonary tumor. Case Presentation: A 61-year-old feminine (by no means smoker) who initially offered with headache and dizziness was recognized with lung adenocarcinoma with a number of mind metastasis (cT2aN3M1b stage IV), and was unfavorable for EGFR and ALK.

The affected person refused to obtain chemotherapy and was solely amenable to mind radiotherapy and focused remedy. After approval from the institutional ethics committee, she underwent concurrent oral apatinib (500 mg/day) with complete mind radiation remedy (WBRT) (37.5Gy) with simultaneous in-field increase (49.5Gy) in 15 fractions with picture guided intensity-modulated radiotherapy.

Three weeks later, neurologic signs totally ceased and a partial response (PR) for the BMs with near-complete decision of peritumoral mind edema was achieved. Chest CT carried out on the identical time and confirmed shrinkage of the lung main with a PR.

The affected person suffered grade III oral mucositis one week after mind radiotherapy and refused additional apatinib. At 12 months after mind radiotherapy, the mind tumors remained properly managed. Conclusions: This is the primary identified documentation of a speedy medical response of apatinib concurrent with mind radiotherapy in a lung adenocarcinoma affected person with symptomatic a number of BMs. Apatinib mixed with mind radiotherapy could possibly be another remedy possibility for BMs from NSCLC, particularly for these with no driver mutation. Further medical trials are required to corroborate this discovery.

Clinical Response to Apatinib Combined With Brain Radiotherapy in EGFR Wild-Type and ALK-Negative Lung Adenocarcinoma With Multiple Brain Metastases.
Clinical Response to Apatinib Combined With Brain Radiotherapy in EGFR Wild-Type and ALK-Negative Lung Adenocarcinoma With Multiple Brain Metastases.

Pattern of Pediatric Supracondylar Fracture Operated at A Rural Teaching Hospital of Nepal: A Descriptive Cross-sectional Study.

Supracondylar fracture of humerus is likely one of the frequent pediatric fractures encountered in our every day medical observe. The goal of this examine is to decide the sample of supracondylar fracture operated at rural educating hospital of Jumla, Karnali Nepal.A descriptive cross sectional examine was carried out at Jumla, Karnali after Institutional Review Committee approval.

Operating room notes from 15 May 2017 to 16 November 2019 had been retrieved to collect the next data: sufferers tackle, age, intercourse, aspect, harm mechanism, displacement, neurovascular harm, concurrent accidents, preliminary administration by conventional bone setters, time between harm and surgical procedure, operative method.

NOD2 antibody
70R-18913 Fitzgerald 50 ul 522 EUR
Description: Rabbit polyclonal NOD2 antibody

Nod2 antibody
10R-6553 Fitzgerald 100 ug 522 EUR
Description: Rat monoclonal Nod2 antibody

NOD2 Antibody
24158-100ul SAB 100ul 468 EUR

NOD2 Antibody
24159-100ul SAB 100ul 468 EUR

NOD2 Antibody
2511-002mg ProSci 0.02 mg 206.18 EUR
Description: NOD2 Antibody: Apaf-1 and NOD1 are members of a new family, which are involved in the regulation of apoptosis and immune response. Each of them contains a caspase recruitment domain (CARD) and a nucleotide-binding oligomerization domain (NOD). A third member in this family was recently identified and designated NOD2. NOD2 interacts with RICK via a homophilic CARD-CARD interaction. NOD2 activates NF-κB, which is regulated by its carboxy-terminal leucine-rich repeat domain that acts as an intracellular receptor for components of bacteria. The variants of NOD2, either a frameshift or a missense, were associated with Crohn's disease that is a main type of chronic inflammatory bowel disease.

NOD2 Antibody
2511-01mg ProSci 0.1 mg 523.7 EUR
Description: NOD2 Antibody: Apaf-1 and NOD1 are members of a new family, which are involved in the regulation of apoptosis and immune response. Each of them contains a caspase recruitment domain (CARD) and a nucleotide-binding oligomerization domain (NOD). A third member in this family was recently identified and designated NOD2. NOD2 interacts with RICK via a homophilic CARD-CARD interaction. NOD2 activates NF-κB, which is regulated by its carboxy-terminal leucine-rich repeat domain that acts as an intracellular receptor for components of bacteria. The variants of NOD2, either a frameshift or a missense, were associated with Crohn's disease that is a main type of chronic inflammatory bowel disease.

NOD2 Antibody
2513-002mg ProSci 0.02 mg 206.18 EUR
Description: NOD2 Antibody: Apaf-1 and NOD1 are members of a new family, which are involved in the regulation of apoptosis and immune response. Each of them contains a caspase recruitment domain (CARD) and a nucleotide-binding oligomerization domain (NOD). A third member in this family was recently identified and designated NOD2. NOD2 interacts with RICK via a homophilic CARD-CARD interaction. NOD2 activates NF-κB, which is regulated by its carboxy-terminal leucine-rich repeat domain that acts as an intracellular receptor for components of bacteria. The variants of NOD2, either a frameshift or a missense, were associated with Crohn's disease that is a main type of chronic inflammatory bowel disease.

NOD2 Antibody
2513-01mg ProSci 0.1 mg 523.7 EUR
Description: NOD2 Antibody: Apaf-1 and NOD1 are members of a new family, which are involved in the regulation of apoptosis and immune response. Each of them contains a caspase recruitment domain (CARD) and a nucleotide-binding oligomerization domain (NOD). A third member in this family was recently identified and designated NOD2. NOD2 interacts with RICK via a homophilic CARD-CARD interaction. NOD2 activates NF-κB, which is regulated by its carboxy-terminal leucine-rich repeat domain that acts as an intracellular receptor for components of bacteria. The variants of NOD2, either a frameshift or a missense, were associated with Crohn's disease that is a main type of chronic inflammatory bowel disease.

NOD2 Antibody
37460-100ul SAB 100ul 302.4 EUR

NOD2 Antibody
1-CSB-PA015915GA01HU Cusabio
  • 716.40 EUR
  • 399.60 EUR
  • 150ul
  • 50ul
Description: A polyclonal antibody against NOD2. Recognizes NOD2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB

NOD2 Antibody
1-CSB-PA876985 Cusabio
  • 380.40 EUR
  • 292.80 EUR
  • 100ul
  • 50ul
Description: A polyclonal antibody against NOD2. Recognizes NOD2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:2000, IHC:1:25-1:100

NOD2 Antibody
1-CSB-PA881021LA01HU Cusabio
  • 380.40 EUR
  • 402.00 EUR
  • 100ug
  • 50ug
Description: A polyclonal antibody against NOD2. Recognizes NOD2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200

NOD2 Antibody
1-CSB-PA446192 Cusabio
  • 380.40 EUR
  • 292.80 EUR
  • 100ul
  • 50ul
Description: A polyclonal antibody against NOD2. Recognizes NOD2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200

NOD2 Antibody
DF12125 Affbiotech 200ul 420 EUR

NOD2 Antibody
R34436-100UG NSJ Bioreagents 100 ug 339.15 EUR
Description: Additional name(s) for this target protein: Nucleotide-binding oligomerization domain-containing protein 2, caspase recruitment domain family, member 15; CARD15

NOD2 Rabbit pAb
A15992-100ul Abclonal 100 ul 369.6 EUR

NOD2 Rabbit pAb
A15992-200ul Abclonal 200 ul 550.8 EUR

NOD2 Rabbit pAb
A15992-20ul Abclonal 20 ul 219.6 EUR

NOD2 Rabbit pAb
A15992-50ul Abclonal 50 ul 267.6 EUR

NOD2 Blocking Peptide
DF12125-BP Affbiotech 1mg 234 EUR

Polyclonal NOD2 Antibody
APR06297G Leading Biology 0.1 mg 790.8 EUR
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD2 . This antibody is tested and proven to work in the following applications:

Polyclonal NOD2 Antibody
APR06298G Leading Biology 0.1 mg 790.8 EUR
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD2 . This antibody is tested and proven to work in the following applications:

NOD2 Conjugated Antibody
C37460 SAB 100ul 476.4 EUR

Human NOD2 ELISA KIT
ELI-23582h Lifescience Market 96 Tests 988.8 EUR

Mouse Nod2 ELISA KIT
ELI-44123m Lifescience Market 96 Tests 1038 EUR

NOD2 ELISA KIT|Human
EF001273 Lifescience Market 96 Tests 826.8 EUR

Bovine NOD2 ELISA KIT
ELI-22273b Lifescience Market 96 Tests 1113.6 EUR

Human NOD2 shRNA Plasmid
20-abx961935 Abbexa
  • 961.20 EUR
  • 1345.20 EUR
  • 150 µg
  • 300 µg

TLR2 & NOD2-Based Adjuvant
VAdv-Ly0016 Creative Biolabs 5 mg 4016.4 EUR
Description: A TLR2 & NOD2-based vaccine adjuvant.

NOD2 Antibody, HRP conjugated
1-CSB-PA881021LB01HU Cusabio
  • 380.40 EUR
  • 402.00 EUR
  • 100ug
  • 50ug
Description: A polyclonal antibody against NOD2. Recognizes NOD2 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

NOD2 Antibody, FITC conjugated
1-CSB-PA881021LC01HU Cusabio
  • 380.40 EUR
  • 402.00 EUR
  • 100ug
  • 50ug
Description: A polyclonal antibody against NOD2. Recognizes NOD2 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

NOD2 Antibody, Biotin conjugated
1-CSB-PA881021LD01HU Cusabio
  • 380.40 EUR
  • 402.00 EUR
  • 100ug
  • 50ug
Description: A polyclonal antibody against NOD2. Recognizes NOD2 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

Nod2 ORF Vector (Rat) (pORF)
ORF071395 ABM 1.0 ug DNA 607.2 EUR

NOD2 ORF Vector (Human) (pORF)
ORF026166 ABM 1.0 ug DNA 486 EUR

Nod2 ORF Vector (Mouse) (pORF)
ORF051499 ABM 1.0 ug DNA 607.2 EUR

NOD2 ELISA Kit (Human) (OKCD02031)
OKCD02031 Aviva Systems Biology 96 Wells 997.2 EUR
Description: Description of target: Involved in gastrointestinal immunity. Upon stimulation by muramyl dipeptide (MDP), a fragment of bacterial peptidoglycan, binds the proximal adapter receptor-interacting RIPK2, which recruits ubiquitin ligases as XIAP, BIRC2, BIRC3 and the LUBAC complex, triggering activation of MAP kinases and activation of NF-kappa-B signaling. This in turn leads to the transcriptional activation of hundreds of genes involved in immune response. Required for MDP-induced NLRP1-dependent CASP1 activation and IL1B release in macrophages.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich Immunoassay;Sensitivity: < 0.055 ng/mL

NOD2 ELISA Kit (Mouse) (OKCA01740)
OKCA01740 Aviva Systems Biology 96 Wells 1015.2 EUR
Description: Description of target: Involved in gastrointestinal immunity. Upon stimulation by muramyl dipeptide (MDP), a fragment of bacterial peptidoglycan, binds the proximal adapter receptor-interacting RIPK2, which recruits ubiquitin ligases as XIAP, BIRC2, BIRC3 and the LUBAC complex, triggering activation of MAP kinases and activation of NF-kappa-B signaling. This in turn leads to the transcriptional activation of hundreds of genes involved in immune response (PubMed:22607974). Required for MDP-induced NLRP1-dependent CASP1 activation and IL1B release in macrophages (PubMed:18511561).;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sanadwich ELISA;Sensitivity: 3.9 pg/mL

NOD2 ELISA Kit (Human) (OKCA02128)
OKCA02128 Aviva Systems Biology 96 Wells 999.6 EUR
Description: Description of target: Involved in gastrointestinal immunity. Upon stimulation by muramyl dipeptide (MDP), a fragment of bacterial peptidoglycan, binds the proximal adapter receptor-interacting RIPK2, which recruits ubiquitin ligases as XIAP, BIRC2, BIRC3 and the LUBAC complex, triggering activation of MAP kinases and activation of NF-kappa-B signaling. This in turn leads to the transcriptional activation of hundreds of genes involved in immune response. Required for MDP-induced NLRP1-dependent CASP1 activation and IL1B release in macrophages.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 6.25 pg/mL

NOD2 ELISA Kit (Human) (OKAN06319)
OKAN06319 Aviva Systems Biology 96 Wells 950.4 EUR
Description: Description of target: This gene is a member of the Nod1/Apaf-1 family and encodes a protein with two caspase recruitment (CARD) domains and six leucine-rich repeats (LRRs). The protein is primarily expressed in the peripheral blood leukocytes. It plays a role in the immune response to intracellular bacterial lipopolysaccharides (LPS) by recognizing the muramyl dipeptide (MDP) derived from them and activating the NFKB protein. Mutations in this gene have been associated with Crohn disease and Blau syndrome. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.055 ng/mL

Anti-CARD15 / NOD2 (Internal) antibody
STJ70992 St John's Laboratory 100 µg 430.8 EUR

h NOD2 inducible lentiviral particles
LVP627 GenTarget 1x107 IFU/ml x 200ul 541.2 EUR
Description: Pre-made over-expression lentivirus for expressing human target: NOD2 (nucleotide-binding oligomerization domain containing 2), [alternative names: ACUG; BLAU; CARD15; CD; CLR16.3; IBD1; NLRC2; NOD2B; PSORAS1]. The sub-cloned codon sequence is identical (100% match) to CDS region in NCBI ID: NM_022162.1. It also contains a RFP-Blasticidin dual selection marker.

Nod2 sgRNA CRISPR Lentivector set (Rat)
K6718501 ABM 3 x 1.0 ug 406.8 EUR

NOD2 3'UTR GFP Stable Cell Line
TU065801 ABM 1.0 ml 1636.8 EUR

Nod2 3'UTR GFP Stable Cell Line
TU264065 ABM 1.0 ml Ask for price

Nod2 3'UTR GFP Stable Cell Line
TU164191 ABM 1.0 ml Ask for price

Nod2 sgRNA CRISPR Lentivector set (Mouse)
K4411601 ABM 3 x 1.0 ug 406.8 EUR

NOD2 sgRNA CRISPR Lentivector set (Human)
K1438601 ABM 3 x 1.0 ug 406.8 EUR

NOD2 Protein Vector (Rat) (pPM-C-HA)
PV285580 ABM 500 ng 1399.2 EUR

NOD2 Protein Vector (Rat) (pPB-C-His)
PV285578 ABM 500 ng 1399.2 EUR

NOD2 Protein Vector (Rat) (pPB-N-His)
PV285579 ABM 500 ng 1399.2 EUR

NOD2 Protein Vector (Rat) (pPM-C-His)
PV285581 ABM 500 ng 1399.2 EUR

Polyclonal NOD2 / CARD15 Antibody (N-Terminus)
APR02524G Leading Biology 0.05mg 580.8 EUR
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD2 / CARD15 (N-Terminus). This antibody is tested and proven to work in the following applications:

Polyclonal NOD2 / CARD15 Antibody (C-Terminus)
APR02525G Leading Biology 0.05mg 580.8 EUR
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD2 / CARD15 (C-Terminus). This antibody is tested and proven to work in the following applications:

NOD2 Protein Vector (Mouse) (pPM-C-HA)
PV205996 ABM 500 ng 1278 EUR

NOD2 Protein Vector (Human) (pPM-C-HA)
PV104664 ABM 500 ng 973.2 EUR

NOD2 Protein Vector (Mouse) (pPB-C-His)
PV205994 ABM 500 ng 1278 EUR

NOD2 Protein Vector (Mouse) (pPB-N-His)
PV205995 ABM 500 ng 1278 EUR

NOD2 Protein Vector (Mouse) (pPM-C-His)
PV205997 ABM 500 ng 1278 EUR

NOD2 Protein Vector (Human) (pPB-C-His)
PV104662 ABM 500 ng 973.2 EUR

NOD2 Protein Vector (Human) (pPB-N-His)
PV104663 ABM 500 ng 973.2 EUR

NOD2 Protein Vector (Human) (pPM-C-His)
PV104665 ABM 500 ng 973.2 EUR

NOD2 3'UTR Luciferase Stable Cell Line
TU015801 ABM 1.0 ml 1636.8 EUR

Nod2 3'UTR Luciferase Stable Cell Line
TU114191 ABM 1.0 ml Ask for price

Nod2 3'UTR Luciferase Stable Cell Line
TU214065 ABM 1.0 ml Ask for price

Nod2 sgRNA CRISPR Lentivector (Rat) (Target 1)
K6718502 ABM 1.0 ug DNA 184.8 EUR

Nod2 sgRNA CRISPR Lentivector (Rat) (Target 2)
K6718503 ABM 1.0 ug DNA 184.8 EUR

Nod2 sgRNA CRISPR Lentivector (Rat) (Target 3)
K6718504 ABM 1.0 ug DNA 184.8 EUR

Nod2 sgRNA CRISPR Lentivector (Mouse) (Target 1)
K4411602 ABM 1.0 ug DNA 184.8 EUR

Nod2 sgRNA CRISPR Lentivector (Mouse) (Target 2)
K4411603 ABM 1.0 ug DNA 184.8 EUR

Nod2 sgRNA CRISPR Lentivector (Mouse) (Target 3)
K4411604 ABM 1.0 ug DNA 184.8 EUR

NOD2 sgRNA CRISPR Lentivector (Human) (Target 1)
K1438602 ABM 1.0 ug DNA 184.8 EUR

NOD2 sgRNA CRISPR Lentivector (Human) (Target 2)
K1438603 ABM 1.0 ug DNA 184.8 EUR

NOD2 sgRNA CRISPR Lentivector (Human) (Target 3)
K1438604 ABM 1.0 ug DNA 184.8 EUR

NOD2 Chemi-Luminescent ELISA Kit (Human) (OKCD03832)
OKCD03832 Aviva Systems Biology 96 Wells 1185.6 EUR
Description: Description of target: Involved in gastrointestinal immunity. Upon stimulation by muramyl dipeptide (MDP), a fragment of bacterial peptidoglycan, binds the proximal adapter receptor-interacting RIPK2, which recruits ubiquitin ligases as XIAP, BIRC2, BIRC3 and the LUBAC complex, triggering activation of MAP kinases and activation of NF-kappa-B signaling. This in turn leads to the transcriptional activation of hundreds of genes involved in immune response. Required for MDP-induced NLRP1-dependent CASP1 activation and IL1B release in macrophages .;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.0412 ng/mL

Polyclonal Goat Anti-CARD15 / NOD2 (Internal) Antibody
APG00059G Leading Biology 0.1mg 580.8 EUR
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-CARD15 / NOD2 (Internal) . This antibody is tested and proven to work in the following applications:

NOD2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
LV645601 ABM 1.0 ug DNA 1626 EUR

NOD2 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)
LV645605 ABM 1.0 ug DNA 1626 EUR

NOD2 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)
LV645606 ABM 1.0 ug DNA 1626 EUR

Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)
K6718505 ABM 3 x 1.0 ug 451.2 EUR

Nucleotide Binding Oligomerization Domain Containing 2 (NOD2) Antibody
abx235781-100ug Abbexa 100 ug 661.2 EUR

Nucleotide Binding Oligomerization Domain Containing 2 (NOD2) Antibody
20-abx114240 Abbexa
  • 878.40 EUR
  • 477.60 EUR
  • 150 ul
  • 50 ul

Nucleotide Binding Oligomerization Domain Containing 2 (NOD2) Antibody
20-abx302321 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)
K4411605 ABM 3 x 1.0 ug 451.2 EUR

NOD2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
K1438605 ABM 3 x 1.0 ug 451.2 EUR

Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)
K6718506 ABM 1.0 ug DNA 200.4 EUR

Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)
K6718507 ABM 1.0 ug DNA 200.4 EUR

Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)
K6718508 ABM 1.0 ug DNA 200.4 EUR

Nucleotide Binding Oligomerization Domain Containing 2 (NOD2) Antibody (HRP)
20-abx316579 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)
K4411606 ABM 1.0 ug DNA 200.4 EUR

Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)
K4411607 ABM 1.0 ug DNA 200.4 EUR

Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3)
K4411608 ABM 1.0 ug DNA 200.4 EUR

NOD2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
K1438606 ABM 1.0 ug DNA 200.4 EUR

NOD2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
K1438607 ABM 1.0 ug DNA 200.4 EUR

NOD2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
K1438608 ABM 1.0 ug DNA 200.4 EUR

Nucleotide Binding Oligomerization Domain Containing 2 (NOD2) Antibody (FITC)
20-abx316580 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

NOD2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA)
LV645602 ABM 1.0 ug DNA 1626 EUR

Nucleotide Binding Oligomerization Domain Containing 2 (NOD2) Antibody (Biotin)
20-abx316581 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) Antibody
20-abx211027 Abbexa
  • 493.20 EUR
  • 360.00 EUR
  • 100 ul
  • 50 ul

Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) Antibody
20-abx339338 Abbexa
  • 493.20 EUR
  • 360.00 EUR
  • 100 ul
  • 50 ul

NOD2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)
LV645603 ABM 1.0 ug DNA 1695.6 EUR

NOD2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)
LV645604 ABM 1.0 ug DNA 1695.6 EUR

Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) CLIA Kit
20-abx190892 Abbexa
  • 9493.20 EUR
  • 5058.00 EUR
  • 1167.60 EUR
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2)CLIA Kit
SCK295Hu-10x96wellstestplate Cloud-Clone 10x96-wells test plate 6777.36 EUR
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in Tissue homogenates, cell lysates and other biological fluids.

Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2)CLIA Kit
SCK295Hu-1x48wellstestplate Cloud-Clone 1x48-wells test plate 663.31 EUR
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in Tissue homogenates, cell lysates and other biological fluids.

Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2)CLIA Kit
SCK295Hu-1x96wellstestplate Cloud-Clone 1x96-wells test plate 896.16 EUR
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in Tissue homogenates, cell lysates and other biological fluids.

Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2)CLIA Kit
SCK295Hu-5x96wellstestplate Cloud-Clone 5x96-wells test plate 3672.72 EUR
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in Tissue homogenates, cell lysates and other biological fluids.

Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) CLIA Kit
4-SCK295Hu Cloud-Clone
  • 6837.60 EUR
  • 3673.20 EUR
  • 896.40 EUR
  • 10 plates of 96 wells
  • 5 plates of 96 wells
  • 1 plate of 96 wells
Description: Double-antibody Sandwich chemiluminescent immunoassay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2)Tissue homogenates, cell lysates and other biological fluids

Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) ELISA Kit
20-abx258642 Abbexa
  • 8853.60 EUR
  • 4719.60 EUR
  • 1093.20 EUR
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Human Nucleotide Binding Oligomerization Domain Containing Protein 2 ELISA Kit (NOD2)
RK01942 Abclonal 96 Tests 625.2 EUR

Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) ELISA Kit
SEK295Hu-10x96wellstestplate Cloud-Clone 10x96-wells test plate 5677.8 EUR
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in tissue homogenates, cell lysates and other biological fluids.

Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) ELISA Kit
SEK295Hu-1x48wellstestplate Cloud-Clone 1x48-wells test plate 572.76 EUR
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in tissue homogenates, cell lysates and other biological fluids.

Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) ELISA Kit
SEK295Hu-1x96wellstestplate Cloud-Clone 1x96-wells test plate 766.8 EUR
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in tissue homogenates, cell lysates and other biological fluids.

Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) ELISA Kit
SEK295Hu-5x96wellstestplate Cloud-Clone 5x96-wells test plate 3090.6 EUR
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in tissue homogenates, cell lysates and other biological fluids.

Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) ELISA Kit
4-SEK295Hu Cloud-Clone
  • 5738.40 EUR
  • 3031.20 EUR
  • 768.00 EUR
  • 10 plates of 96 wells
  • 5 plates of 96 wells
  • 1 plate of 96 wells
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in samples from tissue homogenates, cell lysates and other biological fluids with no significant corss-reactivity with analogues from other species.

Human Nucleotide-binding oligomerization domain-containing protein 2(NOD2) ELISA kit
CSB-EL015915HU-24T Cusabio 1 plate of 24 wells 198 EUR
Description: Quantitativesandwich ELISA kit for measuring Human Nucleotide-binding oligomerization domain-containing protein 2 (NOD2) in samples from serum, plasma, asciticfluid, tissue homogenates, cell lysates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Human Nucleotide-binding oligomerization domain-containing protein 2(NOD2) ELISA kit
1-CSB-EL015915HU Cusabio
  • 964.80 EUR
  • 6118.80 EUR
  • 3244.80 EUR
  • 1 plate of 96 wells
  • 10 plates of 96 wells each
  • 5 plates of 96 wells each
Description: Quantitativesandwich ELISA kit for measuring Human Nucleotide-binding oligomerization domain-containing protein 2(NOD2) in samples from serum, plasma, asciticfluid, tissue homogenates, cell lysates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

ELISA kit for Human NOD2 (Nucleotide Binding Oligomerization Domain Containing Protein 2)
ELK5352 ELK Biotech 1 plate of 96 wells 518.4 EUR
Description: A sandwich ELISA kit for detection of Nucleotide Binding Oligomerization Domain Containing Protein 2 from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids.

Nod3l/ Rat Nod3l ELISA Kit
ELI-11062r Lifescience Market 96 Tests 1063.2 EUR

NOD1 siRNA
20-abx926109 Abbexa
  • 661.20 EUR
  • 878.40 EUR
  • 15 nmol
  • 30 nmol

NOD1 siRNA
20-abx926110 Abbexa
  • 661.20 EUR
  • 878.40 EUR
  • 15 nmol
  • 30 nmol

NOD1 Peptide
5947P ProSci 0.05 mg 197.7 EUR
Description: (CT) NOD1 peptide

NOD3 Peptide
5949P ProSci 0.05 mg 197.7 EUR
Description: (IN) NOD3 peptide

NOD4 Peptide
5951P ProSci 0.05 mg 197.7 EUR
Description: (NT) NOD4 peptide

NOD5 Peptide
5953P ProSci 0.05 mg 197.7 EUR
Description: (NT) NOD5 peptide

NOD6 Peptide
5955P ProSci 0.05 mg 197.7 EUR
Description: (NT) NOD6 peptide

NOD1 Rabbit pAb
A1246-100ul Abclonal 100 ul 369.6 EUR

NOD1 Rabbit pAb
A1246-200ul Abclonal 200 ul 550.8 EUR

NOD1 Rabbit pAb
A1246-20ul Abclonal 20 ul 219.6 EUR

NOD1 Rabbit pAb
A1246-50ul Abclonal 50 ul 267.6 EUR

NOD1 Peptide
42-460P ProSci 0.1 mg 405.6 EUR
Description: (CT) NOD1 Peptide

NOD1 Antibody
5947-002mg ProSci 0.02 mg 206.18 EUR
Description: NOD1 Antibody: NOD1 is a member of the NOD (nucleotide-binding oligomerization domain) family, a group of proteins that are involved in innate immune defense. NOD1 contains an N-terminal caspase recruitment domain (CARD), a centrally located nucleotide-binding domain (NBD), and ten tandem leucine-rich repeats (LRRs) in its C-terminus. The CARD is involved in apoptotic signaling, and NOD1 activates caspase-9 and NF-κB. LRRs participate in protein-protein interactions, and mutations in the NBD may affect the process of oligomerization and subsequent function of the LRR domain. This protein is an intracellular pattern-recognition receptor (PRR) that initiates inflammation in response to a subset of bacteria through the detection of bacterial diaminopimelic acid.

NOD1 Antibody
5947-01mg ProSci 0.1 mg 523.7 EUR
Description: NOD1 Antibody: NOD1 is a member of the NOD (nucleotide-binding oligomerization domain) family, a group of proteins that are involved in innate immune defense. NOD1 contains an N-terminal caspase recruitment domain (CARD), a centrally located nucleotide-binding domain (NBD), and ten tandem leucine-rich repeats (LRRs) in its C-terminus. The CARD is involved in apoptotic signaling, and NOD1 activates caspase-9 and NF-κB. LRRs participate in protein-protein interactions, and mutations in the NBD may affect the process of oligomerization and subsequent function of the LRR domain. This protein is an intracellular pattern-recognition receptor (PRR) that initiates inflammation in response to a subset of bacteria through the detection of bacterial diaminopimelic acid.

NOD3 Antibody
5949-002mg ProSci 0.02 mg 206.18 EUR
Description: NOD3 Antibody: NOD3 is a member of the NOD (nucleotide-binding oligomerization domain) family, a group of proteins that are involved in innate immune defense. NOD3 also known as NLR family CARD containing 3 (NLRC3), is predominantly expressed in the immune system, particularly in T lymphocytes, and its expression is strongly down-regulated following stimulation of the T-cell receptor complex and CD28, suggesting that NOD3 plays a role in attenuating the activation of T cells. NOD3 inhibits NF-kappaB, AP-1 and NFAT transcriptional activation in Jurkat T cells downstream of CD3/CD28 stimulation or treatment with PMA/ionomycin and decreases IL-2 and CD25 mRNA induction in activated cells.

NOD3 Antibody
5949-01mg ProSci 0.1 mg 523.7 EUR
Description: NOD3 Antibody: NOD3 is a member of the NOD (nucleotide-binding oligomerization domain) family, a group of proteins that are involved in innate immune defense. NOD3 also known as NLR family CARD containing 3 (NLRC3), is predominantly expressed in the immune system, particularly in T lymphocytes, and its expression is strongly down-regulated following stimulation of the T-cell receptor complex and CD28, suggesting that NOD3 plays a role in attenuating the activation of T cells. NOD3 inhibits NF-kappaB, AP-1 and NFAT transcriptional activation in Jurkat T cells downstream of CD3/CD28 stimulation or treatment with PMA/ionomycin and decreases IL-2 and CD25 mRNA induction in activated cells.

NOD4 Antibody
5951-002mg ProSci 0.02 mg 206.18 EUR
Description: NOD4 Antibody: NOD4 is a member of the NOD (nucleotide-binding oligomerization domain) family, a group of proteins that are involved in innate immune defense. NOD4 contains a CARD-like domain, a central NOD domain and a large LRR region. NOD4, an IFN-gamma-inducible nuclear protein, plays a role in homeostatic control of innate immunity and in antiviral defense mechanisms. As a key negative regulator of NF-κB and type I interferon signaling, NOD4 may be a useful target for manipulating immune responses against infectious or inflammation-associated diseases, including cancer.

NOD4 Antibody
5951-01mg ProSci 0.1 mg 523.7 EUR
Description: NOD4 Antibody: NOD4 is a member of the NOD (nucleotide-binding oligomerization domain) family, a group of proteins that are involved in innate immune defense. NOD4 contains a CARD-like domain, a central NOD domain and a large LRR region. NOD4, an IFN-gamma-inducible nuclear protein, plays a role in homeostatic control of innate immunity and in antiviral defense mechanisms. As a key negative regulator of NF-κB and type I interferon signaling, NOD4 may be a useful target for manipulating immune responses against infectious or inflammation-associated diseases, including cancer.

NOD5 Antibody
5953-002mg ProSci 0.02 mg 206.18 EUR
Description: NOD5 Antibody: NOD5, also known as NLRX1, is a member of the NOD (nucleotide-binding oligomerization domain) family, a group of proteins that are involved in innate immune defense. NOD5 localizes to the mitochondrial outer membrane and interacts with the virus-induced signaling adapter protein VISA. Unlike a subset of NOD-like receptors (NLRs) such as NOD1 and NOD2 which trigger pro-inflammatory cascades, and other NLRs that induce the caspase 1 inflammasome in response to immune challenges, NOD5 amplifies NF-κB and JNK pathways by inducing reactive oxygen species production.

NOD5 Antibody
5953-01mg ProSci 0.1 mg 523.7 EUR
Description: NOD5 Antibody: NOD5, also known as NLRX1, is a member of the NOD (nucleotide-binding oligomerization domain) family, a group of proteins that are involved in innate immune defense. NOD5 localizes to the mitochondrial outer membrane and interacts with the virus-induced signaling adapter protein VISA. Unlike a subset of NOD-like receptors (NLRs) such as NOD1 and NOD2 which trigger pro-inflammatory cascades, and other NLRs that induce the caspase 1 inflammasome in response to immune challenges, NOD5 amplifies NF-κB and JNK pathways by inducing reactive oxygen species production.

NOD6 Antibody
5955-002mg ProSci 0.02 mg 206.18 EUR
Description: NOD6 Antibody: NOD6, also known as NALP9, is a member of the NALP family, a group of proteins that typically contain a NACHT domain, a NACHT-associated domain (NAD), a C-terminal leucine-rich repeat (LRR) region, and an N-terminal pyrin domain (PYD) and are involved in inflammation and innate immune defense. The bovine NOD6, which has 76% homology to its human counterpart, has been suggested to be an oocyte marker gene. In adult tissues, NALP9 mRNA is expressed exclusively in ovary and testis.

NOD6 Antibody
5955-01mg ProSci 0.1 mg 523.7 EUR
Description: NOD6 Antibody: NOD6, also known as NALP9, is a member of the NALP family, a group of proteins that typically contain a NACHT domain, a NACHT-associated domain (NAD), a C-terminal leucine-rich repeat (LRR) region, and an N-terminal pyrin domain (PYD) and are involved in inflammation and innate immune defense. The bovine NOD6, which has 76% homology to its human counterpart, has been suggested to be an oocyte marker gene. In adult tissues, NALP9 mRNA is expressed exclusively in ovary and testis.

NOD1 antibody
70R-13231 Fitzgerald 100 ul 548.4 EUR
Description: Affinity purified Rabbit polyclonal NOD1 antibody

NOD1 Antibody
25174-100ul SAB 100ul 468 EUR

NOD3 Antibody
25175-100ul SAB 100ul 468 EUR

NOD4 Antibody
25176-100ul SAB 100ul 468 EUR

NOD5 Antibody
25177-100ul SAB 100ul 468 EUR

NOD6 Antibody
25178-100ul SAB 100ul 468 EUR

Nod1 antibody
22788-100ul SAB 100ul 468 EUR

NOD1 Antibody
ABD6378 Lifescience Market 100 ug 525.6 EUR

NOD1 Antibody
32256-100ul SAB 100ul 302.4 EUR

NOD1 Antibody
CSB-PA015914KA01HU- Cusabio each 402 EUR
Description: A polyclonal antibody against NOD1. Recognizes NOD1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200

NOD1 Antibody
CSB-PA015914KA01HU-100ul Cusabio 100ul 466.8 EUR
Description: A polyclonal antibody against NOD1. Recognizes NOD1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200

NOD1 Antibody
DF6378 Affbiotech 200ul 420 EUR

NOD1 Antibody
1-CSB-PA047815 Cusabio
  • 380.40 EUR
  • 292.80 EUR
  • 100ul
  • 50ul
Description: A polyclonal antibody against NOD1. Recognizes NOD1 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:5000, IHC:1:50-1:200

NOD1 Antibody
1-CSB-PA876477 Cusabio
  • 380.40 EUR
  • 292.80 EUR
  • 100ul
  • 50ul
Description: A polyclonal antibody against NOD1. Recognizes NOD1 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:5000, IHC:1:50-1:200

NOD1 Antibody
F54615-0.08ML NSJ Bioreagents 0.08 ml 140.25 EUR
Description: This gene encodes a member of the NOD (nucleotide-binding oligomerization domain) family. This member is a cytosolic protein. It contains an N-terminal caspase recruitment domain (CARD), a centrally located nucleotide-binding domain (NBD), and 10 tandem leucine-rich repeats (LRRs) in its C terminus. The CARD is involved in apoptotic signaling, LRRs participate in protein-protein interactions, and mutations in the NBD may affect the process of oligomerization and subsequent function of the LRR domain. This protein is an intracellular pattern-recognition receptor (PRR) that initiates inflammation in response to a subset of bacteria through the detection of bacterial diaminopimelic acid. Multiple alternatively spliced transcript variants differring in the 5' UTR have been described, but the full-length nature of these variants has not been determined.

NOD1 Antibody
F54615-0.4ML NSJ Bioreagents 0.4 ml 322.15 EUR
Description: This gene encodes a member of the NOD (nucleotide-binding oligomerization domain) family. This member is a cytosolic protein. It contains an N-terminal caspase recruitment domain (CARD), a centrally located nucleotide-binding domain (NBD), and 10 tandem leucine-rich repeats (LRRs) in its C terminus. The CARD is involved in apoptotic signaling, LRRs participate in protein-protein interactions, and mutations in the NBD may affect the process of oligomerization and subsequent function of the LRR domain. This protein is an intracellular pattern-recognition receptor (PRR) that initiates inflammation in response to a subset of bacteria through the detection of bacterial diaminopimelic acid. Multiple alternatively spliced transcript variants differring in the 5' UTR have been described, but the full-length nature of these variants has not been determined.

NOD1 Antibody
RQ5831 NSJ Bioreagents 100 ug 356.15 EUR
Description: Nucleotide-binding oligomerization domain-containing protein 1, also known as CARD4, is a protein receptor that in humans is encoded by the NOD1 gene. NOD1 is a member of NOD-like receptor protein family and is a close relative of NOD2. NOD1 is mapped to 7p14.3. It recognizes bacterial molecules and stimulates an immune reaction. NOD1 protein contains a caspase recruitment domain (CARD). This gene is an intracellular pattern recognition receptor, which is similar in structure to resistant proteins of plants, and mediates innate and acquired immunity by recognizing bacterial molecules containing D-glutamyl-meso-diaminopimelic acid (iE-DAP) moiety. What wore, it has been shown that NOD1 can sense cytosolic microbial products by monitoring the activation state of small Rho GTPases.

NOD1 Antibody
RQ6083 NSJ Bioreagents 100 ug 356.15 EUR
Description: Nucleotide-binding oligomerization domain-containing protein 1, also known as CARD4, is a protein receptor that in humans is encoded by the NOD1 gene. NOD1 is a member of NOD-like receptor protein family and is a close relative of NOD2. NOD1 is mapped to 7p14.3. It recognizes bacterial molecules and stimulates an immune reaction. NOD1 protein contains a caspase recruitment domain (CARD). This gene is an intracellular pattern recognition receptor, which is similar in structure to resistant proteins of plants, and mediates innate and acquired immunity by recognizing bacterial molecules containing D-glutamyl-meso-diaminopimelic acid (iE-DAP) moiety. What wore, it has been shown that NOD1 can sense cytosolic microbial products by monitoring the activation state of small Rho GTPases.

Nod1 Antibody
R31707 NSJ Bioreagents 100 ug 356.15 EUR
Description: Nucleotide-binding oligomerization domain-containing protein 1, also known as CARD4, is a protein receptor that in humans is encoded by the NOD1 gene. It is a member of NOD-like receptor protein family and is a close relative of Nod2. It recognizes bacterial molecules and stimulates an immune reaction. Nod1 contains a caspase recruitment domain (CARD). This gene is an intracellular pattern recognition receptor, which is similar in structure to resistant proteins of plants, and mediates innate and acquired immunity by recognizing bacterial molecules containing D-glutamyl-meso-diaminopimelic acid (iE-DAP) moiety. Additionally, it has been shown that Nod1 can sense cytosolic microbial products by monitoring the activation state of small Rho GTPases.

NOD1 Antibody
R33706-100UG NSJ Bioreagents 100 ug 339.15 EUR
Description: Additional name(s) for this target protein: Nucleotide-binding oligomerization domain containing 1

Mouse Nod1 ELISA KIT
ELI-35306m Lifescience Market 96 Tests 1038 EUR

Human NOD1 ELISA KIT
ELI-46124h Lifescience Market 96 Tests 988.8 EUR

NOD1 ELISA KIT|Human
EF005372 Lifescience Market 96 Tests 826.8 EUR

Nod1 ORF Vector (Rat) (pORF)
ORF071394 ABM 1.0 ug DNA 607.2 EUR

Mouse Nod1 Antibody
abx030859-400ul Abbexa 400 ul 627.6 EUR

Mouse Nod1 Antibody
abx030859-80l Abbexa 80 µl 343.2 EUR

NOD1 cloning plasmid
CSB-CL896866HU-10ug Cusabio 10ug 279.6 EUR
Description: A cloning plasmid for the NOD1 gene.

NOD1 ORF Vector (Human) (pORF)
ORF007140 ABM 1.0 ug DNA 114 EUR

Nod1 ORF Vector (Mouse) (pORF)
ORF051497 ABM 1.0 ug DNA 607.2 EUR

Nod1 ORF Vector (Mouse) (pORF)
ORF051498 ABM 1.0 ug DNA 607.2 EUR

NOD1 3'UTR GFP Stable Cell Line
TU065800 ABM 1.0 ml 1825.2 EUR

Nod1 3'UTR GFP Stable Cell Line
TU264064 ABM 1.0 ml Ask for price

Nod1 3'UTR GFP Stable Cell Line
TU164190 ABM 1.0 ml Ask for price

Human NOD1 shRNA Plasmid
20-abx957041 Abbexa
  • 961.20 EUR
  • 1345.20 EUR
  • 150 µg
  • 300 µg

Mouse NOD1 shRNA Plasmid
20-abx979820 Abbexa
  • 961.20 EUR
  • 1345.20 EUR
  • 150 µg
  • 300 µg

NOD1 Blocking Peptide
DF6378-BP Affbiotech 1mg 234 EUR

nod3l 3'UTR GFP Stable Cell Line
TU264066 ABM 1.0 ml Ask for price

Anti-NLRX1/Nod9 Antibody
A04980-1 BosterBio 100ul 476.4 EUR
Description: Rabbit Polyclonal Antibody for NLRX1 Antibody (NLRX1) detection.tested for IHC, WB in Human, Mouse, Rat.

Anti-CARD4/NOD1 Antibody
PB9294 BosterBio 100ug/vial 400.8 EUR

Anti-NLRX1 / NOD9 antibody
STJ72177 St John's Laboratory 100 µg 430.8 EUR

Polyclonal NOD1 Antibody
APR06661G Leading Biology 0.1 mg 790.8 EUR
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD1 . This antibody is tested and proven to work in the following applications:

Polyclonal NOD3 Antibody
APR06662G Leading Biology 0.1 mg 790.8 EUR
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD3 . This antibody is tested and proven to work in the following applications:

Polyclonal NOD4 Antibody
APR06663G Leading Biology 0.1 mg 790.8 EUR
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD4 . This antibody is tested and proven to work in the following applications:

Polyclonal NOD5 Antibody
APR06664G Leading Biology 0.1 mg 790.8 EUR
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD5 . This antibody is tested and proven to work in the following applications:

Polyclonal NOD6 Antibody
APR06665G Leading Biology 0.1 mg 790.8 EUR
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD6 . This antibody is tested and proven to work in the following applications:

Polyclonal NOD1 Antibody
APR03070G Leading Biology 0.05ml 580.8 EUR
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD1 . This antibody is tested and proven to work in the following applications:

NOD1 Conjugated Antibody
C32256 SAB 100ul 476.4 EUR

NOD1 ELISA Kit (Human) (OKEH08039)
OKEH08039 Aviva Systems Biology 96 Wells 1075.2 EUR
Description: Description of target: This gene encodes a member of the nucleotide-binding oligomerization domain (NOD)-like receptor (NLR) family of proteins. The encoded protein plays a role in innate immunity by acting as a pattern-recognition receptor (PRR) that binds bacterial peptidoglycans and initiates inflammation. This protein has also been implicated in the immune response to viral and parasitic infection. Major structural features of this protein include an N-terminal caspase recruitment domain (CARD), a centrally located nucleotide-binding domain (NBD), and 10 tandem leucine-rich repeats (LRRs) in its C terminus. The CARD is involved in apoptotic signaling, LRRs participate in protein-protein interactions, and mutations in the NBD may affect the process of oligomerization and subsequent function of the LRR domain. Mutations in this gene are associated with asthma, inflammatory bowel disease, Behcet disease and sarcoidosis in human patients.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.078 ng/mL

NOD1 ELISA Kit (Mouse) (OKEH08040)
OKEH08040 Aviva Systems Biology 96 Wells 1310.4 EUR
Description: Description of target: ;Species reactivity: Mouse;Application: ELISA;Assay info: Assay Methodology: Quantitative Competitive ELISA;Sensitivity: 0.096ng/mL

NOD1 ELISA Kit (Human) (OKCA00743)
OKCA00743 Aviva Systems Biology 96 Wells 999.6 EUR
Description: Description of target: Enhances caspase-9-mediated apoptosis. Induces NF-kappa-B activity via RIPK2 and IKK-gamma. Confers responsiveness to intracellular bacterial lipopolysaccharides (LPS). Forms an intracellular sensing system along with ARHGEF2 for the detection of microbial effectors during cell invasion by pathogens. Required for RHOA and RIPK2 dependent NF-kappa-B signaling pathway activation upon S.flexneri cell invasion. Involved not only in sensing peptidoglycan (PGN)-derived muropeptides but also in the activation of NF-kappa-B by Shigella effector proteins IpgB2 and OspB. Recruits NLRP10 to the cell membrane following bacterial infection.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 3.9 pg/mL

NOD1 Protein Vector (Rat) (pPM-C-HA)
PV285576 ABM 500 ng 1429.2 EUR

NOD1 Protein Vector (Rat) (pPB-C-His)
PV285574 ABM 500 ng 1429.2 EUR

NOD1 Protein Vector (Rat) (pPB-N-His)
PV285575 ABM 500 ng 1429.2 EUR

NOD1 Protein Vector (Rat) (pPM-C-His)
PV285577 ABM 500 ng 1429.2 EUR

NOD1 Protein Vector (Human) (pPM-C-HA)
PV028559 ABM 500 ng 394.8 EUR

NOD1 Protein Vector (Mouse) (pPM-C-HA)
PV205988 ABM 500 ng 1278 EUR

NOD1 Protein Vector (Mouse) (pPM-C-HA)
PV205992 ABM 500 ng 1278 EUR

Polyclonal NOD1 Antibody (C-term)
APR03618G Leading Biology 0.1ml 580.8 EUR
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD1 (C-term). This antibody is tested and proven to work in the following applications:

NOD1 Protein Vector (Human) (pPB-C-His)
PV028557 ABM 500 ng 394.8 EUR

Data evaluation was performed utilizing Statistical Package for Social Sciences model 20.Left aspect predominated with 88 (63.7%) and extension kind was frequent in 135 (97.8%). Thirteen (9.4%) sufferers had been initially managed by conventional bonesetters. A complete of 138 kids underwent operative fixation with imply age of seven.47 years and gender ratio of two:1 boy to woman.

Fall from cliff, ladders and rooftops had been the prevailing explanation for harm 73 (52.8%). Average time between harm and surgical procedure was 5.2 days. Closed discount was performed in 100 (72.4%) sufferers whereas open discount was crucial in 38 (27.5%) sufferers.Closed extension kind pediatric supracondylar fracture was frequent in this examine. Fall from cliff, rooftop and ladder are the most important explanation for fracture. Delayed presentation and preliminary administration of the fracture by the standard bonesetters makes supracondylar fracture tougher in useful resource restricted setting like ours.